XML 18 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues:        
Revenues $ 2,871 $ 1,448 $ 7,694 $ 7,335
Expenses        
Cost of product sales 0 0 0 1,399
Research and development 27,498 27,681 57,365 55,174
Selling, general and administrative 13,883 8,659 29,748 14,897
Royalty 0 26 69 113
Total operating expenses 41,381 36,366 87,182 71,583
Loss from operations (38,510) (34,918) (79,488) (64,248)
Interest and other income 2,758 547 9,204 1,143
Interest expense (2,918) (3,035) (5,965) (5,761)
Gain (loss) on foreign currency derivative 63 (223) 43 183
Net loss (38,607) (37,629) (76,206) (68,683)
Unrealized (loss) gain on available for sale investments (11) 130 (36) 338
Comprehensive loss $ (38,618) $ (37,499) $ (76,242) $ (68,345)
Basic and diluted net loss per common share (in dollars per share) $ (0.24) $ (0.34) $ (0.48) $ (0.62)
Weighted average shares outstanding (in shares) 161,569 110,338 157,862 110,253
Product [Member]        
Revenues:        
Revenues $ 0 $ 0 $ 218 $ 1,679
Royalty [Member]        
Revenues:        
Revenues 44 696 1,989 3,018
Collaborative and Other Research and Development [Member]        
Revenues:        
Revenues $ 2,827 $ 752 $ 5,487 $ 2,638